June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Novel compound heterozygous mutations of Leber congenital amaurosis in CCT2
Author Affiliations & Notes
  • Yuriko Minegishi
    National Institute of Sensory Organs, Natl Hosp Org, Tokyo Medical Ctr, Meguro-ku, Japan
  • XunLun Sheng
    Ningxia People’s Hospital, Ningxia Eye Hospital, Ningxia, China
  • Kazuho Ikeo
    Laboratory of DNA Data Analysis, National Institute of Genetics, Shizuoka, Japan
  • Yuri V Sergeev
    National Eye Institute, National Institutes of Health, Bethesda, MD
  • Takeshi Iwata
    National Institute of Sensory Organs, Natl Hosp Org, Tokyo Medical Ctr, Meguro-ku, Japan
  • Footnotes
    Commercial Relationships Yuriko Minegishi, None; XunLun Sheng, None; Kazuho Ikeo, None; Yuri Sergeev, None; Takeshi Iwata, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5424. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuriko Minegishi, XunLun Sheng, Kazuho Ikeo, Yuri V Sergeev, Takeshi Iwata; Novel compound heterozygous mutations of Leber congenital amaurosis in CCT2. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5424.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Leber Congenital Amaurosis (LCA) is a hereditary early-onset retinal dystrophy, which pathoetiology remains to be elucidated. We performed a whole-exome sequencing (WES) analysis on single Chinese LCA family and identified novel compound heterozygous mutations in CCT2. We further investigated the physiological impact of both mutations that leads to disease onset.

Methods: WES analysis was performed on 8 members of LCA pedigree. The mutant proteins were subjected for 3D structure prediction. Protein dynamics were monitored by using patient specific-iPSCs and over expression studies. LC-MS/MS proteomics identified the distinct protein interaction of CCTβ and the mutants. Cell growth was assayed under Si-RNA knock down with lenti-virus rescue. Retinal localization of CCTβ and the associating proteins were examined by immunohistochemistry.

Results: We identified novel compound heterozygous mutations (T400P and R516H) in CCT2, which function as molecular chaperone CCTβ. Two children who have both T400P and R516H mutation exhibited macular degeneration, a hallmark of LCA, with retinal hypoplasia. Other family members having either one of these mutation showed normal macula and retinal structure. Protein structure prediction pointed out structural decay(s) in both mutants. Rapid degradation of T400P and R516H mutants were observed. LC-MS/MS proteomics and the immunoprecipitation and western blotting revealed that T400P has higher affinity to CCTγ, while the R516H exhibited less affinity to CCTγ than wild type CCTβ. Knock down of CCT2 decreased cell growth in 661W, a mouse photoreceptor cell line. Stable expression of CCTβ by lenti-virus in 661W rescued the growth phenotype while the T400P and R516H were less effective. Both CCTβ and CCTγ were expressed in retinal ganglion cells and the photoreceptors. Long term knock down of CCT2 decreased the Gβ1 protein amount in 661W.

Conclusions: We identified novel compound heterozygous mutations in CCT2. The mutants decreased the cell proliferation and Gβ1 supply, which thought to be the fundamental cause for hypoplastic retinal development and macular degeneration in the LCA patients. The CCT2-associating chaperon activity is crucial for retinal homeostasis. The further elucidation of specific clients for each CCT subunits will become increasingly important to understanding the molecular mechanism of LCA onsets.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.